A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence. LJMHR. 2024;24(6):63-87. Accessed February 2, 2026. https://journalspress.uk/index.php/LJMHR/article/view/920